GSK names Luke Miels as next CEO
Miels will formally assume the role on January 1, 2026
Miels will formally assume the role on January 1, 2026
The Hub & Spoke model is designed to extend advanced medical care to a wider community
LEQEMBI was initially approved in China in January 2024 for the treatment of Alzheimer’s disease in patients with mild cognitive impairment
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
RN3161 is engineered to reduce fat while preserving lean mass, setting it apart from current treatment options
The HCl gas is generated continuously which is absorbed in the water scrubber using a chilled falling film system
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
Subscribe To Our Newsletter & Stay Updated